Use and overuse of triptans in Austria - a survey based on nationwide healthcare claims data

The Journal of Headache and Pain
Karin ZebenholzerChristian Wöber

Abstract

To evaluate triptan use and overuse as well as prescription patterns in Austria based on a nationwide healthcare database because data on triptan use and overuse in Austria is missing. We included all persons insured with one of 19 Austrian social security institutions in 2007. Inclusion criteria comprised an age of 18-99 years, known sex, and receipt of insurance benefits. We defined triptan use as ≥1 package of a triptan dispensed in 2007 and triptan overuse as ≥30 defined daily doses dispensed in at least one quarter. Out of 8.295 million inhabitants in Austria, 7,426,412 persons (89.5%) were insured with a social insurance carrier and 5,918,487 persons of those insured (79.7%) fulfilled the inclusion criteria. Among the latter 33,062 persons (0,56%) were triptan users and 1970 (0.033%) were triptan overusers. The estimated proportion of persons with migraine using a triptan was less than 6%. Among users 5.9% were overusers of whom 55% overused triptans in ≥2 quarters of 2007. The median number of days of sick-leave was higher in triptan users than in non-users: due to any reason of sick-leave 12 vs. 10, p < 0.001, due to migraine 3 vs. 2, p < 0.001. The proportion of hospital admissions did not differ between triptan users ...Continue Reading

References

Aug 1, 1992·Cephalalgia : an International Journal of Headache·K EkbomA Kirkham
Apr 1, 1997·British Journal of Clinical Pharmacology·D GaistL F Gram
Apr 29, 2003·Cephalalgia : an International Journal of Headache·C LamplD Klingler
May 19, 2004·Headache·David DodickUNKNOWN Triptan Cardiovascular Safety Expert Panel
Feb 4, 2005·Cephalalgia : an International Journal of Headache·J J H M LohmanUNKNOWN Group of Co-operating Pharmacists Sittard-Geleen and its environs
Feb 9, 2006·Scandinavian Journal of Primary Health Care·Jens SøndergaardMorten Andersen
Jun 20, 2007·European Journal of Clinical Pharmacology·S LugardonM Lapeyre-Mestre
Aug 8, 2007·Cephalalgia : an International Journal of Headache·E PavoneA Panconesi
Jun 6, 2009·Cephalalgia : an International Journal of Headache·J E LafataR B Lipton
May 18, 2010·The Journal of Headache and Pain·Lars Jacob Stovner, Colette Andree
May 20, 2011·Cephalalgia : an International Journal of Headache·F DekkerM D Ferrari
Jun 16, 2011·European Journal of Clinical Pharmacology·Chiara BiagiNicola Montanaro
Dec 6, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M LindeC Andrée
Jul 27, 2012·Cephalalgia : an International Journal of Headache·Daisy S Ng-MakMontse Roset
Nov 8, 2012·Journal of Neurology·Dawn C BuseRichard B Lipton
Apr 18, 2013·Current Opinion in Neurology·Zaza Katsarava, Mark Obermann
Jun 19, 2013·Cephalalgia : an International Journal of Headache·UNKNOWN Headache Classification Committee of the International Headache Society (IHS)
Aug 8, 2013·Cephalalgia : an International Journal of Headache·Giuseppe RobertoElisabetta Poluzzi
Sep 24, 2014·Cephalalgia : an International Journal of Headache·Roberto Da CasArmando A Genazzani
Feb 11, 2015·Cephalalgia : an International Journal of Headache·David BraunsteinJoëlle Micallef
Jan 7, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·Mia Tova MinenDavid Silbersweig

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.